Guidantor No, J&J Is a Buy

摘要

To Wall Street, Johnson & Johnson has been sounding like Dumb & Dumber. In the past year, the health-care giant has gone from nearly grabbing Guidant in a friendly merger to blundering into a bidding war for the cardiac-device maker with rival Boston Scientific. Whoever wins Guidant, I just hope J&J ends up looking D, D, & D.